MedTrace Logo

Calcific Tendinitis: Comparing Minimally Invasive Modalities

NCT02367560 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-06-24

No results posted yet for this study

Summary

Calcific tendinitis is a common and challenging problem in the orthopedic surgeon's office. The chronic and variable course of the condition can lead to dissatisfaction with conservative management. Current standard of care at the Thunder Bay Regional Health Sciences Centre is referral for treatment by either needle decompression therapy by a radiologist or shockwave therapy by a physiotherapist. The purpose of this study is to compare the efficacies of these treatment options.

Conditions

  • Calcific Tendinitis

Interventions

DEVICE

Ultrasound device

Ultrasound device is applied directly to the shoulder at 0.2 mJ/mm2.

PROCEDURE

Needle decompression

Direct manipulation of calcium deposits in the shoulder with a needle to fragment the deposit performed by a radiologist.

PROCEDURE

Shockwave therapy

A physiotherapist performs the shockwave therapy procedure. Treatment is completed in 4 weekly sessions. Treatment involves applying soundwaves directly to the affected shoulder area using an ultrasound device.

DRUG

Depo medrol

Subacromial steroid injection (40 mg depo medrol) is given to the patient to limit irritation following needle decompression.

Sponsors & Collaborators

  • Lakehead University

    lead OTHER

Principal Investigators

  • Jubin Payandeh, MD · Thunder Bay Regional Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2021-06-30
Completion
2022-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02367560 on ClinicalTrials.gov